96401 Chemotherapy anti-neopl square/intramuscular
Also known as: chemo injection, cancer drug injection, subcutaneous chemo
Chemotherapy anti-neoplastic agent administration by subcutaneous or intramuscular injection.
In Plain Language
cancer medicine shot
Clinical Context
Subcutaneous or intramuscular administration of chemotherapy agents for cancer treatment.
RVU Breakdown
| Work RVU | 0.21 |
| Total RVU | 0.21 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
Medicine section codes cover a wide range of non-surgical services. Documentation should include the clinical indication, procedure details, interpretation (if applicable), and any patient-specific findings.
How This Code Compares
With a work RVU of 0.21, this code ranks in the 13th percentile among Medicine codes — 3.7x below the median (0.78). The highest wRVU in this category is 23.92.
Specialties
Frequently Asked Questions
What is CPT code 96401?
CPT 96401 (Chemotherapy anti-neopl square/intramuscular) is a Medicine code. Chemotherapy anti-neoplastic agent administration by subcutaneous or intramuscular injection.
Who uses CPT code 96401?
CPT 96401 is used by Oncology, Hematology. Subcutaneous or intramuscular administration of chemotherapy agents for cancer treatment.
When is CPT 96401 used?
Subcutaneous or intramuscular administration of chemotherapy agents for cancer treatment.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.